Next Article in Journal
Combined Analysis of the Fruit Metabolome and Transcriptome Reveals Candidate Genes Involved in Flavonoid Biosynthesis in Actinidia arguta
Next Article in Special Issue
Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles
Previous Article in Journal
Spatiotemporal Labeling of Melanocytes in Mice
Previous Article in Special Issue
Effect of Amelogenin Coating of a Nano-Modified Titanium Surface on Bioactivity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 19
Issue 5
10.3390/ijms19051470
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Silver Nanoparticles: Two-Faced Neuronal Differentiation-Inducing Material in Neuroblastoma (SH-SY5Y) Cells

by
Ahmed Abdal Dayem
,
Soo Bin Lee
,
Hye Yeon Choi
and
Ssang-Goo Cho
*
Department of Stem Cell and Regenerative Biotechnology, Incurable Disease Animal Model & Stem Cell Institute (IDASI), Konkuk University, Seoul 05029, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2018, 19(5), 1470; https://doi.org/10.3390/ijms19051470
Submission received: 16 April 2018 / Revised: 8 May 2018 / Accepted: 11 May 2018 / Published: 15 May 2018
(This article belongs to the Special Issue Bioactive Nanoparticles)
Browse Figures
Versions Notes

Abstract

:
We have previously demonstrated the potential of biologically synthesized silver nanoparticles (AgNP) in the induction of neuronal differentiation of human neuroblastoma, SH-SY5Y cells; we aimed herein to unveil its molecular mechanism in comparison to the well-known neuronal differentiation-inducing agent, all-trans-retinoic acid (RA). AgNP-treated SH-SY5Y cells showed significantly higher reactive oxygen species (ROS) generation, stronger mitochondrial membrane depolarization, lower dual-specificity phosphatase expression, higher extracellular-signal-regulated kinase (ERK) phosphorylation, lower AKT phosphorylation, and lower expression of the genes encoding the antioxidant enzymes than RA-treated cells. Notably, pretreatment with N-acetyl-l-cysteine significantly abolished AgNP-induced neuronal differentiation, but not in that induced by RA. ERK inhibition, but not AKT inhibition, suppresses neurite growth that is induced by AgNP. Taken together, our results uncover the pivotal contribution of ROS in the AgNP-induced neuronal differentiation mechanism, which is different from that of RA. However, the negative consequence of AgNP-induced neurite growth may be high ROS generation and the downregulation of the expression of the genes encoding the antioxidant enzymes, which prompts the future consideration and an in-depth study of the application of AgNP-differentiated cells in neurodegenerative disease therapy.

Graphical Abstract

1. Introduction

Neuronal differentiation involves the growth, elongation, and bifurcation of neuronal branches (neurites) out of the neuronal cell body. This process is characterized by various cellular changes, such as morphological changes and the increased expression of neuronal differentiation markers, such as β-tubulin III and microtubule-associated protein 2 (MAP2), which are indispensable for the promotion of neurite growth and maturation [1]. The neuronal differentiation process is essential for the recovery of injured neurons [2].
Several immortalized human cell lines, including neuroblastoma (SH-SY5Y) cells, have been developed for neurobiological studies, avoiding the use of animal (mouse and rat)-derived cell lines, which are not identical to their human counterparts [3]. SH-SY5Y cells possess the capacity for the dopaminergic phenotype [4], and are therefore considered to be a suitable in vitro neurotoxicity model for the study of amyotrophic lateral sclerosis, Parkinson’s disease (PD), and Alzheimer’s disease [5,6]. PD, which is a common neurodegenerative disease, is characterized by the accumulation of α-synuclein-containing abnormal protein aggregates (Lewy bodies) and the loss of dopaminergic neurons from the substantia nigra [7].
All-trans-retinoic acid (RA), brain-derived neurotrophic factor, and phorbol esters are well-known inducers of SH-SY5Y cell differentiation into mature neurons [3,8], and several other materials with this capacity have emerged, including vasoactive intestinal peptide, graphene oxide (GO), silver nanoparticles (AgNP), and GO-AgNP nanocomposites [9,10,11,12]. RA plays important roles in cell proliferation, differentiation, and morphogenesis [13,14]. Moreover, its antioxidant and anti-apoptotic functions have been demonstrated in previous studies [15,16,17].
AgNP have been known for approximately 120 years [18] and are well known for their antibacterial [19], antiviral [20], antimycotic [21], interstitial cystitis reducing [22], anti-inflammatory [23], anti-cancer [24], angiogenesis inducing [25], and wound healing [26] activities. AgNP or other metallic nanoparticles (NPs) are commonplace in the consumer products, such as medical devices, and the occupational exposure to these NPs are associated with health hazards, and so, it is important to delve into the biological impacts of AgNP on human cells [27]. Various recent studies have shed light on the crosstalk between AgNP and cellular differentiation, such as their potency to promote the osteogenic differentiation of stem cells [28].
Here, we synthesized AgNP biologically using Escherichia coli (E. coli), through the enzymatic reduction of bulk material silver nitrate, which is considered to be an eco-friendly method [29].
Previously, our group and others have reported on the impact of AgNP in the induction of neuronal differentiation [11,12,30]. However, as with most NPs, the mechanism of action remains obscure. In particular, research elucidating the detailed mechanism of AgNP in neuronal differentiation is lacking, and many issues remain to be addressed. Increased understanding of this mechanism will help to evaluate the therapeutic implications of AgNP in neurodegenerative diseases. Accordingly, the main goal of our study is to characterize the mechanism of AgNP induction of SH-SY5Y cell neuronal differentiation in comparison to the commonly used neuronal differentiation-inducing compound, RA. To achieve this goal, we measured the level of reactive oxygen species (ROS) generation, the expression level of the antioxidant genes, mitochondria membrane depolarization, dual-specificity phosphatase (DUSP) expression level, and the activation of AKT and extracellular-signal-regulated kinase (ERK) signaling in AgNP- and RA-differentiated SH-SY5Y cells. Moreover, in an attempt to find out the mechanism that is involved in AgNP-differentiated cells when compared to RA, before the exposure to AgNP or RA, cells were pretreated with various inhibitors, such as N-acetyl-l-cysteine (NAC), PD98059, and LY-294002, which target ROS generation, ERK, and AKT signalings, respectively. Our results show a marked difference in the mechanism of the neuronal differentiation induced after the exposure to AgNP or RA and open the door for further studies on NP-induced neuronal differentiation and further clinical applications.

2. Results

2.1. Influence of Exposure to AgNP or RA on SH-SY5Y Cell Viability and Differentiation

We biologically synthesized AgNP with an average size of approximately 30 nm, as characterized by transmission electron microscopy (TEM) and dynamic light scattering (DLS) analyses (Figure 1A). The average zeta potential of our synthesized AgNP was −29.10 mV, which confirms the stability of our AgNP solution. In addition, we detected small population of AgNP between 1 and 3 nm as shown in DLS graph (Figure 1A). After the synthesis and the characterization of the synthesized NPs, the further experiments are summarized in Figure 1B. We first examined changes in SH-SY5Y cell viability after time-dependent exposure (24, 48, 72, 96, and 120 h) to AgNP or RA. Neither AgNP nor RA exposure significantly decreased the viability of SH-SY5Y cells up to 72 h (Figure 2A). In contrast, AgNP-exposed cells showed a significant decrease in the cell viability after 96 and 120 h post treatment. Similarly to RA-exposed cells, AgNP-exposed cells showed morphological changes (neurite phenotype) and the high expression of β-tubulin III, a specific neuronal marker (Figure 2B). However, RA treatment resulted in increased neurite length and a higher percentage of cells bearing neurites when compared to AgNP treatment (Figure 2C).

2.2. AgNP and RA Treatment Modulate DUSP Expression Levels and the Activation of Kinase Signaling

DUSPs possess a dual role in dephosphorylating phosphor-tyrosine and the phosphor-serine residues and belong to the classical cysteine-related protein phosphatases [31]. The implication of the DUSPs in neuronal differentiation and the neuronal diseases is shown in the previous reports [31,32].
We compared the expression levels of seven genes encoding DUSPs (DUSP1, DUSP2, DUSP3, DUSP4, DUSP6, DUSP7, and DUSP9) in AgNP- and RA-exposed cells. We also examined the phosphorylation levels of AKT and ERK. DUSP expression markedly decreased in AgNP-treated cells, but it increased in RA-treated cells (Figure 2D), while ERK and AKT phosphorylation levels increased in both AgNP- or RA-exposed cells (Figure 2E). However, AgNP-exposed cells showed increased ERK phosphorylation and decreased AKT phosphorylation when compared to cells that were treated with RA, as shown in the densitometry analysis (Figure 2E, right panel).

2.3. AgNP and RA Treatment Have Differential Effects on Intracellular ROS Generation, Mitochondrial Membrane Depolarization, and Antioxidant Gene Expression

We next analyzed intracellular ROS generation after AgNP and RA treatment. Unlike RA, AgNP-exposed cells exhibited a significant increase in ROS generation after 3 h of exposure (Figure 3A). This was confirmed by spectrophotometric analysis of the fluorescence intensity of ROS signaling (Figure 3B). We confirmed the source of ROS generation by measuring the potency of AgNP mitochondrial membrane depolarization using 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1), which specifically measures the mitochondrial membrane potential (ΔΨm).
For this purpose, cells were treated with AgNP (0.1, 0.2, 0.3, and 0.4 μM). JC-1 monomer fluorescence emission significantly increased in a dose-dependent manner (Figure 3C), with a low ratio of aggregates/monomers (Figure 3D).
To circumvent the harmful consequences of excessive ROS generation, such as damage to DNA, RNA, proteins, and lipids, various cellular enzymatic defense mechanisms exist to detoxify excess ROS, including enzymatic defense molecules (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), and peroxiredoxin (PRX) and non-enzymatic defense molecules (glutathione, vitamin C, and vitamin E) [33]. The majority of intracellular ROS originates from superoxide (O2−•), produced by the single electron reduction of O2. Copper/zinc SOD (SOD1), manganese SOD (SOD2), and extracellular SOD (SOD3), which are located in the cytosol, mitochondria, and extracellular matrix, respectively [34], play pivotal roles in the conversion of superoxide to hydrogen peroxide (H2O2) and oxygen. GPX, PRX, and CAT enzymes are responsible for the removal of H2O2 via its conversion to water and oxygen [35].
Accordingly, we measured the expression levels of the genes that are encoding the antioxidant enzymes SOD1, SOD2, SOD3, CAT, GPX1, GPX2, GPX3, and GPX4 using quantitative real-time polymerase chain reaction (PCR). AgNP- and RA-treated cells showed differential modulation in antioxidant gene expression levels. AgNP-treated cells displayed significantly decreased expression of these enzymes, particularly SOD2 and CAT, but no significant effects on GPX expression was detected (Figure 3E). In contrast, RA-exposed cells showed an upregulation of genes encoding the antioxidant enzymes, such as SODs, CAT, and GPX4 (Figure 3E).

2.4. A ROS Scavenging Agent and ERK and AKT Inhibitors Have Differential Effects on AgNP- and RA-Induced Neuronal Differentiation

The above results indicate the differential modulation of ROS generation and ERK and AKT phosphorylation in AgNP- and RA-exposed cells. Accordingly, we next characterized the importance of ROS generation and the phosphorylation of ERK and AKT on AgNP- or RA-induced neuronal differentiation via pretreatment with inhibitors that were targeting these elements.
First, we examined the contribution of ROS to AgNP- and RA-induced neuronal differentiation by pretreating the cells with the ROS scavenging agent NAC. Immunofluorescence analysis revealed that NAC pretreatment led to significant reductions in neurite growth and β-tubulin III expression in AgNP-differentiated cells (Figure 4A). In contrast, NAC pretreatment did not have any significant effect on RA-induced neuronal differentiation (Figure 4A).
To determine the importance of ERK and AKT signaling in AgNP- and RA-differentiated cells, we pretreated cells with ERK (PD98059) and AKT (LY-294002) pathway inhibitors. PD98059 pretreatment markedly suppressed neurite growth and β-tubulin III expression in AgNP-differentiated cells, while pretreatment with LY-294002 had no effect (Figure 4A). Conversely, LY-294002 pretreatment, but not PD98059 pretreatment, decreased the neurite growth and β-tubulin III expression in RA-treated SH-SY5Y cells (Figure 4A). The analysis of neurite length and the percentage of neurite-bearing cells were carried out using the neurite tracing plugin NeuriteTrace in ImageJ (Figure 4B). Moreover, MAP2 and β-tubulin III expression levels were significantly decreased upon PD98059 pretreatment in AgNP-differentiated cells only, which was confirmed by quantitative real time PCR (Figure 4C). In RA-differentiated cells, LY-294002, but not PD98059 pretreatment, suppressed the expression of neuronal differentiation markers (Figure 4C).
Taken together, the results suggest that AgNP- and RA-differentiated cells displayed differential mechanisms of neuronal differentiation induction; in particular, ROS and ERK signaling are essential for AgNP-induced neurite growth and AKT signaling is mainly involved in RA-related neurite growth (Figure 5).

3. Discussion

NPs possess high functionality when compared to the original bulk particle (inert material), which is attributed to their small size and large surface area. There is a plethora of scientific reports that examine the link between NPs and the promotion of the neuronal differentiation, as well as their possible application in nerve injury repair, which is a challenging problem in the neuroscience [36,37,38]. For instance, iron oxide NP treatment led to increased neurite growth and an increase in the number of neurite-bearing PC12 cells [39]. Gold nanorod-exposed NG108-15 cells that were cultured on dishes coated with either poly (4-styrenesulfonic acid) or SiO2 show 20–25% increase in neurite outgrowth when compared to cells not exposed to gold nanorods [40].
Several plausible mechanisms regarding the potency of NPs to induce neuronal differentiation and increase neurite growth have been proposed, such as transcription factor activation [40], changes in the expression of cytoskeleton-related genes, and changes in growth hormone receptor signaling [39].
AgNPs are well-known for their excellent antibacterial activity, which is attributed to the release of silver ions (Ag+), slow oxidation, and binding and penetration of the cell membrane, leading to bacterial cell damage and death [41,42]. Despite their wide range of biological functions and clinical applications, higher concentrations of AgNP have harmful and deleterious health effects [43]. However, the toxic action of AgNP depends on the particle size, surface area, concentration, and the exposure time [44,45,46].
In our study, AgNPs were biologically synthesized by reducing AgNO3 to Ag with an average size of 30 nm (Figure 1A). We previously showed the potential of these biologically synthesized AgNP in stimulating neurite outgrowth via the upregulation of specific neuronal differentiation markers and increased activation of ERK and AKT signaling. We also demonstrated their potential to generate ROS [11].
A wide range of microbes, such as bacteria, fungi, and algae represents a factories for reduction and the ultimate green synthesis of the NPs [47]. A recent interesting report biologically synthesized gold NPs using glycolipids that purified from lactobacillus casei and produced small size NPs [48]. The biological synthesis of the NPs avoids using toxic chemicals and produces a stable NPs, which is attributed to the biomolecules in the culture supernatant [49,50].
Consistent with our findings, AgNP have been shown to play an important function in the initiation and elongation phases of SH-SY5Y cells, with no cytotoxicity [12,30,51].
Several studies show the impact of AgNP on differentiation of the mesenchymal stem cells [52,53,54,55,56] and the proliferation and toxicity of stem cell [57,58,59]. Of the note, there are various reports showing the molecular functions of the biologically synthesized AgNP. For instance, a biologically synthesized AgNP using E. coli efficiently induced the cytotoxicity of F9 teratocarcinoma stem cells in a dose-increment manner, which attributed to high ROS generation, mitochondrial dysfunction, and high production of the lactate dehydrogenase [60]. On the other hand, F9 teratocarcinoma stem cells that were exposed to low concentration of AgNP differentiated into a neuronal lineage, which was evidenced by the high expression of the neuronal specific markers [60]. Another interesting study proved the potential of the biologically synthesized AgNP in the induction of cytotoxicity in human lung epithelial adenocarcinoma cell line in a dose-dependent manner, which is mediated by induction of ROS generation, depolarization of the mitochondrial membrane, and the production of the lactate dehydrogenase [61].
AgNP synthesized with Bacillus licheniformis inhibited the angiogenesis when treated with 500 nM that shown in the inhibition to the growth and the migration of the bovine retinal endothelial cells with and without treatment of the vascular endothelial growth factor [62]. In addition, the anti-cancer capacity of the biologically synthesized AgNP using bacteria via various mechanisms is shown in several literatures [63,64,65]. The cellular responses and the biological functions of AgNP in a wide range of cells lines, including, normal, cancer, and stem cells are summarized and reviewed elsewhere [45]. As data demonstrating the relevance of AgNP to neurite growth continue to accrue, it will become essential to determine the factors, which are relevant to AgNP function in promotion of the neuronal growth. To achieve this purpose, we examined the mechanism of AgNP-induced neurite growth when compared to RA-induced differentiation.
AgNP- or RA-exposed SH-SY5Y cells did not show significant suppression of cell viability. We confirmed the potential of AgNP to induce neurite growth by immunofluorescence staining of the neuronal differentiation marker β-tubulin III. Of note, the effect of AgNP on ROS generation and cytotoxicity is a concentration-dependent concept. In this regard, our previous study showed that, as the exposure dose of AgNP increased, the cell toxicity significantly increased [11]. Our current results revealed that the cytotoxicity was significantly increased as the time of exposure increased, in particular, with 96 and 120 h of exposure (Figure 2A). In addition, we detected a significant depolarization of the mitochondrial membrane in a dose-increment manner (Figure 3C,D).
The dephosphorylation of phosphoserine, phosphothreonine, and phosphotyrosine residues on kinases is mainly performed by the DUSPs, which are a subclass of the protein tyrosine phosphatase superfamily [66]. AgNP-treated SH-SY5Y cells displayed decreased DUSP expression, while RA-exposed cells displayed increased expression. The upregulation of DUSP by RA treatment is shown previously [32], and the modulation of DUSP by NPs is reported [67]. Both RA and AgNP treatments resulted in the activation of AKT and ERK signaling; however, AgNP caused higher ERK phosphorylation and lower AKT phosphorylation than RA. The crosslink between AgNP exposure and ERK activation is shown in the previous reports [25,68,69]. The AKT pathway is an important component of RA signaling [70,71], which is consistent with our results.
Recently, rather than focusing on their deleterious effects, reports on the physiological roles of ROS in cellular function and differentiation have increased. ROS generation can modulate osteogenesis [72], neuronal differentiation [73], and neurogenesis [74], and its optimal concentration is important for the stimulation of crucial signaling pathways, and consequently, the regulation of various cellular functions, such as proliferation, differentiation, and cell death [75,76]. ROS generation was significantly increased upon AgNP treatment but not RA treatment. Moreover, JC-1 staining suggested an interaction between AgNP and the mitochondrial membrane, leading to its depolarization. Additionally, a significant suppression of the expression of antioxidant genes, such as SOD and CAT, was detected in AgNP-exposed cells, while they were significantly upregulated in RA-treated cells. The link between RA and the upregulation of SOD2 has also been reported previously [77,78]. Collectively, the results suggest that the mitochondria may be involved in AgNP-induced ROS generation, as consistent with previous reports showing the role of the mitochondria in AgNP-induced ROS generation [79,80].
To reveal the role of ROS signaling in AgNP-induced neuronal differentiation, treatment with the ROS scavenger NAC was performed before AgNP exposure. The neurite growth enhancement that was observed with AgNP was abolished by NAC pretreatment, which did not affect RA-differentiated cells. A link between ROS generation and ERK activation has been previously reported [81,82,83], implicating ERK signaling in the promotion of neuronal differentiation and nervous system development [83,84].
In conclusion, AgNPs interact with the mitochondrial membrane, leading to mitochondrial membrane polarization, and resulting in intracellular ROS generation. ROS generation may increase ERK phosphorylation and suppress DUSP expression, thus enhancing the expression of neuronal differentiation genes and resulting in neurite growth. The signaling pathway that is involved in the AgNP-mediated neuronal differentiation of SH-SY5Y cells differs from that of RA-mediated differentiation, in which activation of AKT signaling and high DUSP expression ultimately upregulates the expression of neuronal differentiation genes (Figure 5). Our study also highlights the impact of ROS on AgNP-induced neurite growth and provides a model that can be applied in future studies to explore the biological functions of various NPs possessing ROS generation potential, such as silicate, gold, and iron oxide NPs, in neuronal differentiation, and their possible therapeutic applications in neurodegenerative diseases. There is a broad spectrum of microorganisms that needs further studies for characterization of their roles in the biological synthesis of NPs and their mechanisms need to be revealed as well. Also, the larger scale application of bacterial-based NPs synthesis needs further consideration. Both AgNP and RA are in common in the promotion of the neurite growth. However, increased cytotoxicity, enhanced oxidative stress, and decreased expression of genes encoding the antioxidant enzymes after AgNP treatment could be a negative effect of AgNP-induced differentiation, and this will open the door for novel in-depth studies on the suitability of the nanomaterials in the treatment of neurodegenerative disorders in the future.

4. Materials and Methods

4.1. Materials

Fetal bovine serum (FBS) and high-glucose Dulbecco’s modified Eagle medium (DMEM) were purchased from Hyclone (Logan, UT, USA) for SH-SY5Y cell culture. Penicillin (50 U/mL) and streptomycin (50 μg/mL) were obtained from Invitrogen (Carlsbad, CA, USA). RA, NAC, PD98059, LY-294002, and epoxomicin were purchased from Sigma-Aldrich (St. Louis, MO, USA).

4.2. AgNP Synthesis and Characterization

AgNPs were biologically synthesized, as previously described [11,85]. In brief, the culture of E. coli was carried out using Luria-Bertani medium (without sodium chloride), which was incubated for 21 h at 37 °C at 120 rpm on the shaker. Then, the culture supernatant, which is used for AgNP synthesis, was prepared via the centrifugation at 10,000 rpm. For AgNP synthesis, 1 mM AgNO3 solution was added to the culture supernatant and incubated for 24 h. The synthesized AgNP was characterized by Biochrom WPA Biowave II UV-vis spectroscopy (Biochrom, Cambridge, UK). TEM (JEM-1200EX; EM Lab Services, Topeka, KS, USA) to determine the shape and size of the synthesized AgNP and the particle size was analyzed by DLS on a Zetasizer Nano ZS90 (Malvern Instruments, Worcestershire, UK), as previously described [11]. The zeta potential of AgNP was measured with a zeta potential analyzer (ELSZ-1000, Otsuka Electronics Co., Ltd., Osaka, Japan).

4.3. SH-SY5Y Cell Culture and Treatment with AgNP and RA

Human neuroblastoma SH-SY5Y cells were cultured in DMEM supplemented with 10% FBS, penicillin (50 U/mL), and streptomycin (50 μg/mL), and were maintained at 37 °C with 5% CO2. The AgNP/RA treatment protocol is illustrated in Figure 1B. Prior to the neuronal differentiation induction with 0.1 μM AgNP or 1 μM RA, the growth medium was exchanged with medium containing 1% FBS. AgNP and RA were diluted to the indicated concentrations using this medium and were incubated with the cells for five days.

4.4. Cytotoxicity Assays

Cells were treated with AgNP or RA at the indicated concentrations for various time points in triplicate wells and were analyzed for cytotoxic effects using the EZ-Cytox cell viability kit (Daeil Lab Service, Seoul, Korea). SH-SY5Y cells were seeded onto 96-well plates at 1 × 104 cells/well, incubated overnight to reach confluence, and then treated with media containing 0.1 μM AgNP or 1 μM RA for 24, 48, 72, 96, and 120 h. Afterward, the treated medium was replaced with fresh medium containing 10% EZ-Cytox and was incubated at 37 °C for 3 h with 5% CO2 in the dark. To quantify the cell viability, the optical densities of the treated wells were measured at 480 nm using a Bio-RAD x-MarkTM spectrophotometer (Bio-Rad Laboratories, Hercules, CA, USA). AgNP- and RA-treated cells were compared with mock-treated cells, which were arbitrarily set to 100% viability.

4.5. Immunofluorescence Staining

For immunofluorescence, glass slides (12/12 mm, Superior-Marienfeld, Lauda-Königshofen, Germany) were rinsed in 80% ethanol for 15 min, washed with distilled water, dried, and stored in a dry place until use. The glass slides were placed in the wells of 12-well plates, and SH-SY5Y cells (4 × 104 cells/well) were seeded onto the prepared glass slides and incubated overnight. After five days of differentiation, the cells were prepared for immunofluorescence, as described previously [11]. Normal goat serum (10%) was used as a blocking solution. After incubation with a primary monoclonal antibody against β-tubulin III (Sigma Aldrich, St. Louis, MO, USA), the cells were incubated with secondary antibody (Dylight 549-conjugated goat anti-mouse antibody, Jackson ImmunoResearch Labs, West Grove, PA, USA). TO-PRO-3 (Molecular Probes, Eugene, OR, USA) was used for nuclear staining, and images were captured using a Leica laser scanning confocal microscope.

4.6. Neurite Growth Analysis

After immunofluorescence staining for neuronal differentiation markers, the neurite length in AgNP- or RA-exposed cells was calibrated using the neurite tracing plugin NeuriteTrace in ImageJ software (Version 1.50i, National Institutes of Health, Bethesda, MD, USA) [86]. To calculate the percentage of neurite bearing cells, we divided the number of cells that displayed visually distinguishable neurites by the total number of cells in the field, and then multiplied by 100 to obtain the percentage. Neurite-bearing cells were selected when they possessed at least one neurite growth that was longer than the cell body.

4.7. Intracellular ROS Measurements and Quantification of Antioxidant Gene Expression

To monitor intracellular ROS levels, we used a fluorescent probe, 2′,7′-dichlorofluorescin diacetate (H2DCFDA; Molecular Probes, Eugene, OR, USA), which is cell-permeable and is broadly used to monitor the levels of intracellular ROS, such as hydrogen peroxide (H2O2) [87] and various reactive intermediates [88]. Before exposure to AgNP or RA or 100 μM H2O2 (Sigma Aldrich, St. Louis, MO, USA) for 1, 3, 6, and 12 h, SH-SY5Y cells were pretreated with NAC (1 mM) for 1 h and then incubated with 10 μM H2DCFDA at 37 °C for 30 min in the dark. Afterward, the cells were washed twice, covered with PBS, and the fluorescence intensity was analyzed using a Spectra MAX Gemini EM (Molecular Devices, San Jose, CA, USA) dual-scanning microplate spectrofluorometer with excitation and emission at 490 and 530 nm, respectively. Fluorescent images were captured on a Nikon Eclipse TE2000-U fluorescent inverted microscope (Nikon, Tokyo, Japan). In addition, we measured the expression of genes that were encoding the antioxidant enzymes, including SOD1, SOD2, SOD3, CAT, GPX1, GPX2, GPX3, and GPX4 after AgNP and RA treatment using quantitative real-time PCR analysis.

4.8. RNA Extraction, cDNA Synthesis, and mRNA Expression Analysis

Total RNA was isolated from cells using the Easy-Blue total RNA extraction kit (iNtRON Biotechnology, Seongnam, Korea), according to the manufacturer’s instructions and quantified on a NanoDrop (ND1000) spectrophotometer (Nanodrop Technologies Inc., Wilmington, DE, USA). cDNA was synthesized from 2 μg total RNA using MMLV reverse transcriptase (Promega, Madison, WI, USA) and oligo (dT). PCR amplification was performed using 2× PCR Master Mix Solution (Elpis Biotech, Daejeon, Korea), and products were analyzed on 1–2% agarose gels. For quantitative real-time PCR, the quantification of expression changes was performed using SYBR Green master mix (Elpis Biotech, Daejeon, Korea) and an Applied Biosystems 7500 real-time PCR system. The expression level of target genes was normalized to the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and the calculation of the relative expression was performed using the comparative Ct or ΔΔCt method. All primer sequences used are listed in Table 1.

4.9. ΔΨm Analysis Using JC-1

The aim of this experiment is to measure the alteration in ΔΨm after the exposure to various concentrations of AgNP. Changes in ΔΨm were investigated using the lipophilic cationic carbocyanine dye JC-1 (Molecular Probes, T-3168), which is a ratiometric tool for measuring mitochondrial polarization [89]. Upon excitation at 490 nm, J-aggregates emit red fluorescence at 590 nm in intact mitochondria and J-monomers emit a green fluorescence at 540 nm in the depolarized mitochondria.
For the qualitative fluorescence analysis, SH-SY5Y cells were seeded onto the prepared glass slides, which were placed in the wells of 12-well plates and were incubated overnight. The preparation of the glass slides was explained in detail in the immunofluorescence staining section. After treating SH-SY5Y cells with 0.1, 0.2, 0.3, and 0.4 µM AgNP for 24 h, JC-1 was added to serum-free medium to a final concentration of 10 μM and then incubated at 37 °C for 15 min. The images of the fluorescent signals were captured with Leica laser scanning confocal microscope (Leica Microsystems, Wetzlar, Germany).
For the quantitative measurement of the fluorescent intensity, SH-SY5Y cells were seeded onto 96-well plate and were subjected to AgNP treatments and JC-1 staining, as described before. Afterward, the fluorescent intensities were measured with a Spectra MAX Gemini EM dual-scanning microplate spectrofluorometer [90]. The ratio of the fluorescent intensities between the monomers (red) and the aggregates (green) is an indicator of ΔΨm [91]. The low ratio of red/green florescent intensities indicate the mitochondrial depolarization

4.10. Western Blot Analysis

Total protein was extracted from AgNP- and RA-exposed cells, as previously described [11], and the protein concentration of the supernatant was quantified using Bradford protein assay reagent (Bio-Rad Laboratories). Lysates (40 µg protein) were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and were then transferred onto nitrocellulose membranes. The membranes were then blocked using 5% (w/v) skimmed milk dissolved in Tris-buffered saline (TBS) with 1% (v/v) Tween-20 (TBST) for 1 h; incubated overnight with anti-phosphorylated AKT, anti-AKT, anti-phosphorylated ERK1/2, anti-β-Actin (all Santa Cruz Biotechnology, Dallas, TX, USA), and anti-ERK1/2 (Cell Signaling Technology, Beverly, MA, USA) primary antibodies, and then incubated with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) for 2 h. All of the antibodies were diluted at the manufacturers’ recommended concentrations in 5% (w/v) dry milk dissolved in PBST. Protein signals were detected on X-ray films using an enhanced chemiluminescence kit (Amersham Biosciences, Piscataway, NJ, USA). The densitometry analysis was carried out using ImageJ software and the graphic data represent the ratio between the intensity of the proteins and the intensity of the housekeeping protein, β-Actin.

4.11. Statistical Analyses

All of the experiments were performed in three independent times. Excel program 2010 (Microsoft, Redmond, WA, USA) was used to calculate the mean ± standard deviation of the obtained data. Data are presented as the mean ± standard deviation (SD). All of the statistical analyses were carried out with GraphPad InStat V. 3.0 software (GraphPad Software, San Diego, CA, USA) using one-way analysis of variance (ANOVA) or two-tailed Student’s t-test. The data were considered significant at p < 0.05.

Author Contributions

A.A.D. and S.-G.C. conceived and designed the experiments; A.A.D. performed the experiments; S.B.L. and H.Y.C. analyzed the data; A.A.D. and S.-G.C. wrote the paper.

Acknowledgments

This paper was supported by Konkuk University in 2017.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

AgNPsilver nanoparticle
RAall-trans-retinoic acid
ROSreactive oxygen species
DUSPdual-specificity phosphatase
NACN-acetyl-l-cysteine
ERKextracellular-signal-regulated kinase
AKTAK mouse strain transforming
PDParkinson’s disease
SH-SY5Yhuman neuroblastoma cell line
GOgraphene oxide
TEMtransmission electron microscopy
DLSdynamic light scattering
SODsuperoxide dismutase
CATcatalase
GPXglutathione peroxidase
PRXPeroxiredoxin
MAP2Microtubule-associated protein 2
H2O2hydrogen peroxide
PD98059ERK inhibitor
LY-294002AKT inhibitor
H2DCFDA2′,7′-dichlorofluorescin diacetate
ΔΨmmitochondrial membrane potential
DMEMDulbecco’s modified Eagle’s medium
FBSfetal bovine serum
PBSphosphate-buffered saline
TBSTris-buffered saline
JC-15,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide

References

  1. Lopes, F.M.; Schröder, R.; da Frota Júnior, M.L.C.; Zanotto-Filho, A.; Müller, C.B.; Pires, A.S.; Meurer, R.T.; Colpo, G.D.; Gelain, D.P.; Kapczinski, F.; et al. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for parkinson disease studies. Brain Res. 2010, 1337, 85–94. [Google Scholar] [CrossRef] [PubMed]
  2. Schiwy, N.; Brazda, N.; Müller, H.W. Enhanced regenerative axon growth of multiple fibre populations in traumatic spinal cord injury following scar-suppressing treatment. Eur. J. Neurosci. 2009, 30, 1544–1553. [Google Scholar] [CrossRef] [PubMed]
  3. Shipley, M.M.; Mangold, C.A.; Szpara, M.L. Differentiation of the SH-SY5Y human neuroblastoma cell line. J. Vis. Exp. JoVE 2016, 53193. [Google Scholar] [CrossRef] [PubMed]
  4. Xicoy, H.; Wieringa, B.; Martens, G.J. The SH-SY5Y cell line in Parkinson’s disease research: A systematic review. Mol. Neurodegener. 2017, 12, 10. [Google Scholar] [CrossRef] [PubMed]
  5. Krishna, A.; Biryukov, M.; Trefois, C.; Antony, P.M.; Hussong, R.; Lin, J.; Heinäniemi, M.; Glusman, G.; Köglsberger, S.; Boyd, O.; et al. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for parkinson’s disease. BMC Genom. 2014, 15, 1154. [Google Scholar] [CrossRef] [PubMed]
  6. Kovalevich, J.; Langford, D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. In Neuronal Cell Culture; Springer Protocols Humana Press: Totowa, NJ, USA, 2013; pp. 9–21. [Google Scholar]
  7. Dexter, D.T.; Jenner, P. Parkinson disease: From pathology to molecular disease mechanisms. Free Radic. Biol. Med. 2013, 62, 132–144. [Google Scholar] [CrossRef] [PubMed]
  8. Duester, G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 134, 921–931. [Google Scholar] [CrossRef] [PubMed]
  9. Lv, M.; Zhang, Y.; Liang, L.; Wei, M.; Hu, W.; Li, X.; Huang, Q. Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line. Nanoscale 2012, 4, 3861–3866. [Google Scholar] [CrossRef] [PubMed]
  10. Pence, J.C.; Shorter, N.A. In vitro differentiation of human neuroblastoma cells caused by vasoactive intestinal peptide. Cancer Res. 1990, 50, 5177–5183. [Google Scholar] [PubMed]
  11. Dayem, A.A.; Kim, B.; Gurunathan, S.; Choi, H.Y.; Yang, G.; Saha, S.K.; Han, D.; Han, J.; Kim, K.; Kim, J.H. Biologically synthesized silver nanoparticles induce neuronal differentiation of SH-SY5Y cells via modulation of reactive oxygen species, phosphatases, and kinase signaling pathways. Biotechnol. J. 2014, 9, 934–943. [Google Scholar] [CrossRef] [PubMed]
  12. Gurunathan, S.; Kim, J.-H. Graphene oxide–silver nanoparticles nanocomposite stimulates differentiation in human neuroblastoma cancer cells (SH-SY5Y). Int. J. Mol. Sci. 2017, 18, 2549. [Google Scholar] [CrossRef] [PubMed]
  13. Cañón, E.; Cosgaya, J.M.; Scsucova, S.; Aranda, A. Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol. Biol. Cell 2004, 15, 5583–5592. [Google Scholar] [CrossRef] [PubMed]
  14. Konta, T.; Xu, Q.; Furusu, A.; Nakayama, K.; Kitamura, M. Selective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid. J. Biol. Chem. 2001, 276, 12697–12701. [Google Scholar] [CrossRef] [PubMed]
  15. Das, N.P. Effects of vitamin a and its analogs on nonenzymatic lipid peroxidation in rat brain mitochondria. J. Neurochem. 1989, 52, 585–588. [Google Scholar] [CrossRef] [PubMed]
  16. Ahlemeyer, B.; Bauerbach, E.; Plath, M.; Steuber, M.; Heers, C.; Tegtmeier, F.; Krieglstein, J. Retinoic acid reduces apoptosis and oxidative stress by preservation of sod protein level. Free Radic. Biol. Med. 2001, 30, 1067–1077. [Google Scholar] [CrossRef]
  17. Ahlemeyer, B.; Krieglstein, J. Retinoic acid reduces staurosporine-induced apoptotic damage in chick embryonic neurons by suppressing reactive oxygen species production. Neurosci. Lett. 1998, 246, 93–96. [Google Scholar] [CrossRef]
  18. Nowack, B.; Krug, H.F.; Height, M. 120 years of nanosilver history: Implications for policy makers. Environ. Sci. Technol. 2011, 45, 1177–1183. [Google Scholar] [CrossRef] [PubMed]
  19. Sharma, V.K.; Yngard, R.A.; Lin, Y. Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 2009, 145, 83–96. [Google Scholar] [CrossRef] [PubMed]
  20. Elechiguerra, J.L.; Burt, J.L.; Morones, J.R.; Camacho-Bragado, A.; Gao, X.; Lara, H.H.; Yacaman, M.J. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 2005, 3, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Kim, K.-J.; Sung, W.S.; Suh, B.K.; Moon, S.-K.; Choi, J.-S.; Kim, J.G.; Lee, D.G. Antifungal activity and mode of action of silver nano-particles on candida albicans. Biometals 2009, 22, 235–242. [Google Scholar] [CrossRef] [PubMed]
  22. Boucher, W.; Stern, J.; Kotsinyan, V.; Kempuraj, D.; Papaliodis, D.; Cohen, M.; Theoharides, T. Intravesical nanocrystalline silver decreases experimental bladder inflammation. J. Urol. 2008, 179, 1598–1602. [Google Scholar] [CrossRef] [PubMed]
  23. Bhol, K.C.; Schechter, P.J. Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Digest. Dis. Sci. 2007, 52, 2732–2742. [Google Scholar] [CrossRef] [PubMed]
  24. Yeasmin, S.; Datta, H.K.; Chaudhuri, S.; Malik, D.; Bandyopadhyay, A. In-vitro anti-cancer activity of shape controlled silver nanoparticles (AGNPS) in various organ specific cell lines. J. Mol. Liq. 2017, 242, 757–766. [Google Scholar] [CrossRef]
  25. Kang, K.; Lim, D.-H.; Choi, I.-H.; Kang, T.; Lee, K.; Moon, E.-Y.; Yang, Y.; Lee, M.-S.; Lim, J.-S. Vascular tube formation and angiogenesis induced by polyvinylpyrrolidone-coated silver nanoparticles. Toxicol. Lett. 2011, 205, 227–234. [Google Scholar] [CrossRef] [PubMed]
  26. Tian, J.; Wong, K.K.; Ho, C.M.; Lok, C.N.; Yu, W.Y.; Che, C.M.; Chiu, J.F.; Tam, P.K. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007, 2, 129–136. [Google Scholar] [CrossRef] [PubMed]
  27. Rim, K.-T.; Song, S.-W.; Kim, H.-Y. Oxidative DNA damage from nanoparticle exposure and its application to workers’ health: A literature review. Saf. Health Work 2013, 4, 177–186. [Google Scholar] [CrossRef] [PubMed]
  28. Qin, H.; Zhu, C.; An, Z.; Jiang, Y.; Zhao, Y.; Wang, J.; Liu, X.; Hui, B.; Zhang, X.; Wang, Y. Silver nanoparticles promote osteogenic differentiation of human urine-derived stem cells at noncytotoxic concentrations. Int. J. Nanomed. 2014, 9, 2469. [Google Scholar] [CrossRef] [PubMed]
  29. Sintubin, L.; Verstraete, W.; Boon, N. Biologically produced nanosilver: Current state and future perspectives. Biotechnol. Bioeng. 2012, 109, 2422–2436. [Google Scholar] [CrossRef] [PubMed]
  30. Alon, N.; Miroshnikov, Y.; Perkas, N.; Nissan, I.; Gedanken, A.; Shefi, O. Substrates coated with silver nanoparticles as a neuronal regenerative material. Int. J. Nanomed. 2014, 9, 23. [Google Scholar]
  31. Bhore, N.; Wang, B.-J.; Chen, Y.-W.; Liao, Y.-F. Critical roles of dual-specificity phosphatases in neuronal proteostasis and neurological diseases. Int. J. Mol. Sci. 2017, 18, 1963. [Google Scholar] [CrossRef] [PubMed]
  32. Kim, S.Y.; Han, Y.-M.; Oh, M.; Kim, W.-K.; Oh, K.-J.; Lee, S.C.; Bae, K.-H.; Han, B.-S. DUSP4 regulates neuronal differentiation and calcium homeostasis by modulating ERK1/2 phosphorylation. Stem Cells Dev. 2014, 24, 686–700. [Google Scholar] [CrossRef] [PubMed]
  33. Franco, R.; Sánchez-Olea, R.; Reyes-Reyes, E.M.; Panayiotidis, M.I. Environmental toxicity, oxidative stress and apoptosis: Menage a trois. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 2009, 674, 3–22. [Google Scholar] [CrossRef] [PubMed]
  34. Dasuri, K.; Zhang, L.; Keller, J.N. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 2013, 62, 170–185. [Google Scholar] [CrossRef] [PubMed]
  35. Kim, G.H.; Kim, J.E.; Rhie, S.J.; Yoon, S. The role of oxidative stress in neurodegenerative diseases. Exp. Neurobiol. 2015, 24, 325–340. [Google Scholar] [CrossRef] [PubMed]
  36. Riggio, C.; Calatayud, M.P.; Hoskins, C.; Pinkernelle, J.; Sanz, B.; Torres, T.E.; Ibarra, M.R.; Wang, L.; Keilhoff, G.; Goya, G.F.; et al. Poly-l-lysine-coated magnetic nanoparticles as intracellular actuators for neural guidance. Int. J. Nanomed. 2012, 7, 3155. [Google Scholar]
  37. Riggio, C.; Calatayud, M.P.; Giannaccini, M.; Sanz, B.; Torres, T.E.; Fernández-Pacheco, R.; Ripoli, A.; Ibarra, M.R.; Dente, L.; Cuschieri, A.; et al. The orientation of the neuronal growth process can be directed via magnetic nanoparticles under an applied magnetic field. Nanomed. Nanotechnol. Biol. Med. 2014, 10, 1549–1558. [Google Scholar] [CrossRef] [PubMed]
  38. Richert, L.; Vetrone, F.; Yi, J.H.; Zalzal, S.F.; Wuest, J.D.; Rosei, F.; Nanci, A. Surface nanopatterning to control cell growth. Adv. Mater. 2008, 20, 1488–1492. [Google Scholar] [CrossRef]
  39. Kim, J.A.; Lee, N.; Kim, B.H.; Rhee, W.J.; Yoon, S.; Hyeon, T.; Park, T.H. Enhancement of neurite outgrowth in PC12 cells by iron oxide nanoparticles. Biomaterials 2011, 32, 2871–2877. [Google Scholar] [CrossRef] [PubMed]
  40. Paviolo, C.; Haycock, J.W.; Yong, J.; Yu, A.; Stoddart, P.R.; McArthur, S.L. Laser exposure of gold nanorods can increase neuronal cell outgrowth. Biotechnol. Bioeng. 2013, 110, 2277–2291. [Google Scholar] [CrossRef] [PubMed]
  41. Krutyakov, Y.A.; Kudrinskiy, A.A.; Olenin, A.Y.; Lisichkin, G.V. Synthesis and properties of silver nanoparticles: Advances and prospects. Russ. Chem. Rev. 2008, 77, 233–257. [Google Scholar] [CrossRef]
  42. Maillard, J.-Y.; Hartemann, P. Silver as an antimicrobial: Facts and gaps in knowledge. Crit. Rev. Microbiol. 2013, 39, 373–383. [Google Scholar] [CrossRef] [PubMed]
  43. Xu, F.; Piett, C.; Farkas, S.; Qazzaz, M.; Syed, N.I. Silver nanoparticles (AGNPS) cause degeneration of cytoskeleton and disrupt synaptic machinery of cultured cortical neurons. Mol. Brain 2013, 6, 29. [Google Scholar] [CrossRef] [PubMed]
  44. Grosse, S.; Evje, L.; Syversen, T. Silver nanoparticle-induced cytotoxicity in rat brain endothelial cell culture. Toxicol. In Vitro 2013, 27, 305–313. [Google Scholar] [CrossRef] [PubMed]
  45. Zhang, X.-F.; Shen, W.; Gurunathan, S. Silver nanoparticle-mediated cellular responses in various cell lines: An in vitro model. Int. J. Mol. Sci. 2016, 17, 1603. [Google Scholar] [CrossRef] [PubMed]
  46. Butler, K.S.; Peeler, D.J.; Casey, B.J.; Dair, B.J.; Elespuru, R.K. Silver nanoparticles: Correlating nanoparticle size and cellular uptake with genotoxicity. Mutagenesis 2015, 30, 577–591. [Google Scholar] [CrossRef] [PubMed]
  47. Menon, S.; Rajeshkumar, S.; Kumar, V. A review on biogenic synthesis of gold nanoparticles, characterization, and its applications. Resour.-Effic. Technol. 2017, 3, 516–527. [Google Scholar] [CrossRef]
  48. Kikuchi, F.; Kato, Y.; Furihata, K.; Kogure, T.; Imura, Y.; Yoshimura, E.; Suzuki, M. Formation of gold nanoparticles by glycolipids of lactobacillus casei. Sci. Rep. 2016, 6, 34626. [Google Scholar] [CrossRef] [PubMed]
  49. Safavi, A.; Zeinali, S.; Yazdani, M. Synthesis of biologically stable gold nanoparticles using imidazolium-based amino acid ionic liquids. Amino Acids 2012, 43, 1323–1330. [Google Scholar] [CrossRef] [PubMed]
  50. Soltani Nejad, M.; Shahidi Bonjar, G.H.; Khaleghi, N. Biosynthesis of gold nanoparticles using streptomyces fulvissimus isolate. Nanomed. J. 2015, 2, 153–159. [Google Scholar]
  51. Nissan, I.; Schori, H.; Lipovsky, A.; Alon, N.; Gedanken, A.; Shefi, O. Effect of different densities of silver nanoparticles on neuronal growth. J. Nanopart. Res. 2016, 18, 221. [Google Scholar] [CrossRef]
  52. He, W.; Kienzle, A.; Liu, X.; Müller, W.E.; Elkhooly, T.A.; Feng, Q. In vitro effect of 30 nm silver nanoparticles on adipogenic differentiation of human mesenchymal stem cells. J. Biomed. Nanotechnol. 2016, 12, 525–535. [Google Scholar] [CrossRef] [PubMed]
  53. Liu, X.; He, W.; Fang, Z.; Kienzle, A.; Feng, Q. Influence of silver nanoparticles on osteogenic differentiation of human mesenchymal stem cells. J. Biomed. Nanotechnol. 2014, 10, 1277–1285. [Google Scholar] [CrossRef] [PubMed]
  54. Samberg, M.E.; Loboa, E.G.; Oldenburg, S.J.; Monteiro-Riviere, N.A. Silver nanoparticles do not influence stem cell differentiation but cause minimal toxicity. Nanomedicine 2012, 7, 1197–1209. [Google Scholar] [CrossRef] [PubMed]
  55. Yu, X.Q.; Xu, L.X. Effects of silver nanoparticles on the in vitro culture and differentiation of human bone marrow-derived mesenchymal cells. In Materials Science Forum; Trans Tech Publications: Zurich, Switzerland, 2016; pp. 1307–1312. [Google Scholar]
  56. He, W.; Elkhooly, T.A.; Liu, X.; Cavallaro, A.; Taheri, S.; Vasilev, K.; Feng, Q. Silver nanoparticle based coatings enhance adipogenesis compared to osteogenesis in human mesenchymal stem cells through oxidative stress. J. Mater. Chem. B 2016, 4, 1466–1479. [Google Scholar] [CrossRef]
  57. Rajanahalli, P.; Stucke, C.J.; Hong, Y. The effects of silver nanoparticles on mouse embryonic stem cell self-renewal and proliferation. Toxicol. Rep. 2015, 2, 758–764. [Google Scholar] [CrossRef] [PubMed]
  58. Liu, F.; Mahmood, M.; Xu, Y.; Watanabe, F.; Biris, A.S.; Hansen, D.K.; Inselman, A.; Casciano, D.; Patterson, T.A.; Paule, M.G.; et al. Effects of silver nanoparticles on human and rat embryonic neural stem cells. Front. Neurosci. 2015, 9, 115. [Google Scholar] [CrossRef] [PubMed]
  59. Peng, H.; Zhang, X.; Wei, Y.; Liu, W.; Li, S.; Yu, G.; Fu, X.; Cao, T.; Deng, X. Cytotoxicity of silver nanoparticles in human embryonic stem cell-derived fibroblasts and an L-929 cell line. J. Nanomater. 2012, 2012, 160145. [Google Scholar] [CrossRef] [Green Version]
  60. Han, J.W.; Gurunathan, S.; Choi, Y.-J.; Kim, J.-H. Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity-and differentiation-mediated cancer therapy. Int. J. Nanomed. 2017, 12, 7529. [Google Scholar] [CrossRef] [PubMed]
  61. Han, J.W.; Gurunathan, S.; Jeong, J.-K.; Choi, Y.-J.; Kwon, D.-N.; Park, J.-K.; Kim, J.-H. Oxidative stress mediated cytotoxicity of biologically synthesized silver nanoparticles in human lung epithelial adenocarcinoma cell line. Nanoscale Res. Lett. 2014, 9, 459. [Google Scholar] [CrossRef] [PubMed]
  62. Kalishwaralal, K.; Banumathi, E.; Pandian, S.R.K.; Deepak, V.; Muniyandi, J.; Eom, S.H.; Gurunathan, S. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf. B Biointerfaces 2009, 73, 51–57. [Google Scholar] [CrossRef] [PubMed]
  63. Sriram, M.I.; Kanth, S.B.M.; Kalishwaralal, K.; Gurunathan, S. Antitumor activity of silver nanoparticles in dalton’s lymphoma ascites tumor model. Int. J. Nanomed. 2010, 5, 753. [Google Scholar]
  64. Gurunathan, S.; Park, J.H.; Han, J.W.; Kim, J.-H. Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by bacillus tequilensis and calocybe indica in MDA-MB-231 human breast cancer cells: Targeting p53 for anticancer therapy. Int. J. Nanomed. 2015, 10, 4203. [Google Scholar] [CrossRef] [PubMed]
  65. Gurunathan, S.; Han, J.W.; Eppakayala, V.; Jeyaraj, M.; Kim, J.-H. Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. BioMed Res. Int. 2013, 2013, 535796. [Google Scholar] [CrossRef] [PubMed]
  66. Owens, D.; Keyse, S. Differential regulation of map kinase signalling by dual-specificity protein phosphatases. Oncogene 2007, 26, 3203–3213. [Google Scholar] [CrossRef] [PubMed]
  67. Comfort, K.K.; Maurer, E.I.; Braydich-Stolle, L.K.; Hussain, S.M. Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells. ACS Nano 2011, 5, 10000–10008. [Google Scholar] [CrossRef] [PubMed]
  68. Castiglioni, S.; Cazzaniga, A.; Perrotta, C.; Maier, J.A. Silver nanoparticles-induced cytotoxicity requires ERK activation in human bladder carcinoma cells. Toxicol. Lett. 2015, 237, 237–243. [Google Scholar] [CrossRef] [PubMed]
  69. Rinna, A.; Magdolenova, Z.; Hudecova, A.; Kruszewski, M.; Refsnes, M.; Dusinska, M. Effect of silver nanoparticles on mitogen-activated protein kinases activation: Role of reactive oxygen species and implication in DNA damage. Mutagenesis 2014, 30, 59–66. [Google Scholar] [CrossRef] [PubMed]
  70. Qiao, J.; Paul, P.; Lee, S.; Qiao, L.; Josifi, E.; Tiao, J.R.; Chung, D.H. Pi3k/Akt and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation. Biochem. Biophys. Res. Commun. 2012, 424, 421–426. [Google Scholar] [CrossRef] [PubMed]
  71. Miloso, M.; Villa, D.; Crimi, M.; Galbiati, S.; Donzelli, E.; Nicolini, G.; Tredici, G. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is erk independent and Pkc dependent. J. Neurosci. Res. 2004, 75, 241–252. [Google Scholar] [CrossRef] [PubMed]
  72. Lee, N.K.; Choi, Y.G.; Baik, J.Y.; Han, S.Y.; Jeong, D.-w.; Bae, Y.S.; Kim, N.; Lee, S.Y. A crucial role for reactive oxygen species in rankl-induced osteoclast differentiation. Blood 2005, 106, 852–859. [Google Scholar] [CrossRef] [PubMed]
  73. Tsatmali, M.; Walcott, E.C.; Makarenkova, H.; Crossin, K.L. Reactive oxygen species modulate the differentiation of neurons in clonal cortical cultures. Mol. Cell. Neurosci. 2006, 33, 345–357. [Google Scholar] [CrossRef] [PubMed]
  74. Le Belle, J.E.; Orozco, N.M.; Paucar, A.A.; Saxe, J.P.; Mottahedeh, J.; Pyle, A.D.; Wu, H.; Kornblum, H.I. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a Pi3k/Akt-dependant manner. Cell Stem Cell 2011, 8, 59–71. [Google Scholar] [CrossRef] [PubMed]
  75. Coso, S.; Harrison, I.; Harrison, C.B.; Vinh, A.; Sobey, C.G.; Drummond, G.R.; Williams, E.D.; Selemidis, S. Nadph oxidases as regulators of tumor angiogenesis: Current and emerging concepts. Antioxid. Redox Signal. 2012, 16, 1229–1247. [Google Scholar] [CrossRef] [PubMed]
  76. Storz, P. Forkhead homeobox type o transcription factors in the responses to oxidative stress. Antioxid. Redox Signal. 2011, 14, 593–605. [Google Scholar] [CrossRef] [PubMed]
  77. Kiningham, K.K.; Cardozo, Z.-A.; Cook, C.; Cole, M.P.; Stewart, J.C.; Tassone, M.; Coleman, M.C.; Spitz, D.R. All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-κb. Free Radic. Biol. Med. 2008, 44, 1610–1616. [Google Scholar] [CrossRef] [PubMed]
  78. Silvis, A.M.; McCormick, M.L.; Spitz, D.R.; Kiningham, K.K. Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid. Redox Biol. 2016, 7, 88–96. [Google Scholar] [CrossRef] [PubMed]
  79. Hsin, Y.-H.; Chen, C.-F.; Huang, S.; Shih, T.-S.; Lai, P.-S.; Chueh, P.J. The apoptotic effect of nanosilver is mediated by a ROS-and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 2008, 179, 130–139. [Google Scholar] [CrossRef] [PubMed]
  80. Chairuangkitti, P.; Lawanprasert, S.; Roytrakul, S.; Aueviriyavit, S.; Phummiratch, D.; Kulthong, K.; Chanvorachote, P.; Maniratanachote, R. Silver nanoparticles induce toxicity in a549 cells via ros-dependent and ros-independent pathways. Toxicol. In Vitro 2013, 27, 330–338. [Google Scholar] [CrossRef] [PubMed]
  81. Goldsmit, Y.; Erlich, S.; Pinkas-Kramarski, R. Neuregulin induces sustained reactive oxygen species generation to mediate neuronal differentiation. Cell. Mol. Neurobiol. 2001, 21, 753–769. [Google Scholar] [CrossRef] [PubMed]
  82. Katoh, S.; Mitsui, Y.; KITANI, K.; SUZUKI, T. Hyperoxia induces the neuronal differentiated phenotype of PC12 cells via a sustained activity of mitogen-activated protein kinase induced by Bcl-2. Biochem. J. 1999, 338, 465–470. [Google Scholar] [CrossRef] [PubMed]
  83. Wang, X.; Wang, Z.; Yao, Y.; Li, J.; Zhang, X.; Li, C.; Cheng, Y.; Ding, G.; Liu, L.; Ding, Z. Essential role of ERK activation in neurite outgrowth induced by α-lipoic acid. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 2011, 1813, 827–838. [Google Scholar] [CrossRef] [PubMed]
  84. Kato, T.; Ohtani-Kaneko, R.; Ono, K.; Okado, N.; Shiga, T. Developmental regulation of activated erk expression in the spinal cord and dorsal root ganglion of the chick embryo. Neurosci. Res. 2005, 52, 11–19. [Google Scholar] [CrossRef] [PubMed]
  85. Gurunathan, S.; Kalishwaralal, K.; Vaidyanathan, R.; Venkataraman, D.; Pandian, S.R.K.; Muniyandi, J.; Hariharan, N.; Eom, S.H. Biosynthesis, purification and characterization of silver nanoparticles using escherichia coli. Colloids Surf. B Biointerfaces 2009, 74, 328–335. [Google Scholar] [CrossRef] [PubMed]
  86. Pool, M.; Thiemann, J.; Bar-Or, A.; Fournier, A.E. Neuritetracer: A novel imageJ plugin for automated quantification of neurite outgrowth. J. Neurosci. Methods 2008, 168, 134–139. [Google Scholar] [CrossRef] [PubMed]
  87. Bułdak, R.J.; Polaniak, R.; Bułdak, Ł.; Żwirska-Korczala, K.; Skonieczna, M.; Monsiol, A.; Kukla, M.; Duława-Bułdak, A.; Birkner, E. Short-term exposure to 50 Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells. Bioelectromagnetics 2012, 33, 641–651. [Google Scholar] [CrossRef] [PubMed]
  88. LeBel, C.P.; Ischiropoulos, H.; Bondy, S.C. Evaluation of the probe 2′, 7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 1992, 5, 227–231. [Google Scholar] [CrossRef] [PubMed]
  89. Perelman, A.; Wachtel, C.; Cohen, M.; Haupt, S.; Shapiro, H.; Tzur, A. JC-1: Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis. 2012, 3, e430. [Google Scholar] [CrossRef] [PubMed]
  90. Xu, S.; Nam, S.; Kim, J.; Das, R.; Choi, S.; Nguyen, T.; Quan, X.; Choi, S.; Chung, C.; Lee, E. Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress. Cell Death Dis. 2015, 6, e1976. [Google Scholar] [CrossRef] [PubMed]
  91. Jana, S.; Sinha, M.; Chanda, D.; Roy, T.; Banerjee, K.; Munshi, S.; Patro, B.S.; Chakrabarti, S. Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson’s disease. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2011, 1812, 663–673. [Google Scholar] [CrossRef] [PubMed]
Ijms 19 01470 g001 550
Figure 1. Characterization and experimental scheme for the biologically synthesized silver nanoparticles (AgNP). (A) Characterization of the biologically synthesized AgNP. The biological synthesis of AgNP was performed through the reduction of the bulk material silver nitrate (AgNO3) by Escherichia coli nitrate reductase. Transmission electron microscopy (TEM) imaging of the biologically synthesized AgNP shows a spherical shape with an approximate size of 30 nm. The histogram shows the synthesized AgNP size distribution, as measured by dynamic light scattering (DLS) and presence of small population of the particles between 1 and 3 nm. Scale bar = 50 nm. (B) Schematic of the experimental procedures used to compare the neuronal differentiation processes of AgNP- and all-trans-retinoic acid (RA)-exposed neuroblastoma (SH-SY5Y) cells.
Figure 1. Characterization and experimental scheme for the biologically synthesized silver nanoparticles (AgNP). (A) Characterization of the biologically synthesized AgNP. The biological synthesis of AgNP was performed through the reduction of the bulk material silver nitrate (AgNO3) by Escherichia coli nitrate reductase. Transmission electron microscopy (TEM) imaging of the biologically synthesized AgNP shows a spherical shape with an approximate size of 30 nm. The histogram shows the synthesized AgNP size distribution, as measured by dynamic light scattering (DLS) and presence of small population of the particles between 1 and 3 nm. Scale bar = 50 nm. (B) Schematic of the experimental procedures used to compare the neuronal differentiation processes of AgNP- and all-trans-retinoic acid (RA)-exposed neuroblastoma (SH-SY5Y) cells.
Ijms 19 01470 g001
Ijms 19 01470 g002 550
Figure 2. Effects of AgNP and RA on the viability, differentiation, Dual-specificity phosphatase (DUSP expression, and AKT and ERK activation status of SH-SY5Y cells. (A) SH-SY5Y cells were incubated with 0.1 μM AgNP or 1 μM RA for 24, 48, 72, 96, and 120 h and viability was analyzed using the EZ-Cytox cell viability kit. SH-SY5Y cells exposed to AgNP for 96 and 72 h showed a significant cytotoxicity. The experiment was performed in triplicate. (B) Immunocytochemistry analysis: incubation of SH-SY5Y cells with 0.1 μM AgNP or 1 μM RA for five days. Both RA-exposed and AgNP-exposed cells showed morphological changes (neurite phenotype) and high expression of β-tubulin III. Scale bars, 100 μm. (C) Neurite length and the percentage of neurite-bearing cells were measured using the neurite tracing plugin NeuriteTrace in ImageJ. Both AgNP- and RA-exposed cells significantly promoted the neurite length and increased the percentage of neurite-bearing cells. * p < 0.05; ** p < 0.01. (D) Determination of DUSP1, DUSP2, DUSP3, DUSP4, DUSP6, DUSP7, and DUSP9 expression levels in SH-SY5Y cells after 5 d of incubation with 0.1 μM AgNP or 1 μM RA. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a housekeeping gene. DUSPs expression level was markedly decreased and increased in AgNP- and RA-treated cells, respectively. (E) Western blot analysis was performed to determine the phosphorylation levels of extracellular-signal-regulated kinase (ERK) and AKT in 0.1 μM AgNP- or 1 μM RA-exposed SH-SY5Y cells. Western blot analysis: SH-SY5Y cells treated with 0.1 μM AgNP or 1 mM RA showed high phosphorylation of ERK and AKT signalings. AgNP-exposed cells showed higher phosphorylation of ERK than that shown in RA-exposed cells and higher AKT phosphorylation was detected in RA-exposed cells than that of AgNP-treated cells as depicted in the densitometry analysis (right panel).
Figure 2. Effects of AgNP and RA on the viability, differentiation, Dual-specificity phosphatase (DUSP expression, and AKT and ERK activation status of SH-SY5Y cells. (A) SH-SY5Y cells were incubated with 0.1 μM AgNP or 1 μM RA for 24, 48, 72, 96, and 120 h and viability was analyzed using the EZ-Cytox cell viability kit. SH-SY5Y cells exposed to AgNP for 96 and 72 h showed a significant cytotoxicity. The experiment was performed in triplicate. (B) Immunocytochemistry analysis: incubation of SH-SY5Y cells with 0.1 μM AgNP or 1 μM RA for five days. Both RA-exposed and AgNP-exposed cells showed morphological changes (neurite phenotype) and high expression of β-tubulin III. Scale bars, 100 μm. (C) Neurite length and the percentage of neurite-bearing cells were measured using the neurite tracing plugin NeuriteTrace in ImageJ. Both AgNP- and RA-exposed cells significantly promoted the neurite length and increased the percentage of neurite-bearing cells. * p < 0.05; ** p < 0.01. (D) Determination of DUSP1, DUSP2, DUSP3, DUSP4, DUSP6, DUSP7, and DUSP9 expression levels in SH-SY5Y cells after 5 d of incubation with 0.1 μM AgNP or 1 μM RA. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a housekeeping gene. DUSPs expression level was markedly decreased and increased in AgNP- and RA-treated cells, respectively. (E) Western blot analysis was performed to determine the phosphorylation levels of extracellular-signal-regulated kinase (ERK) and AKT in 0.1 μM AgNP- or 1 μM RA-exposed SH-SY5Y cells. Western blot analysis: SH-SY5Y cells treated with 0.1 μM AgNP or 1 mM RA showed high phosphorylation of ERK and AKT signalings. AgNP-exposed cells showed higher phosphorylation of ERK than that shown in RA-exposed cells and higher AKT phosphorylation was detected in RA-exposed cells than that of AgNP-treated cells as depicted in the densitometry analysis (right panel).
Ijms 19 01470 g002
Ijms 19 01470 g003 550
Figure 3. Modulation of reactive oxygen species (ROS) generation, mitochondrial depolarization, and the genes encoding the antioxidant enzymes expression in AgNP- and RA-treated SH-SY5Y cells. (A,B) ROS generation in SH-SY5Y cells pretreated with NAC (1 mM), and were then treated with 0.1 μM of AgNP or 1 μM of RA or 100 μM of Hydrogen peroxide (H2O2) was measured by fluorescence microscopy (A) and a fluorometric method (B). AgNP-exposed cells showed a significant ROS generation, in particular, after 3 h and 6 h of incubation, which is inhibited by NAC pretreatment. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) SH-SY5Y cells were incubated with AgNP (0.1, 0.2, 0.3, and 0.4 μM) and the mitochondrial membrane potential (ΔΨm) was measured using JC-1 staining. The qualitative analysis fluorescence intensities of the monomer (green) and an aggregate (red) form was analyzed with the fluorescence confocal microscopy. Scale bars, 100 μm. (D) The quantitative analysis of the ratio of aggregate and the monomer was determined using dual-scanning microplate spectrofluorometer. AgNP showed a significant depolarization of the mitochondrial membrane in a dose-dependent manner in SH-SY5Y cells. * p < 0.05; ** p < 0.01; *** p < 0.001. (E) Expression of genes encoding the antioxidant enzymes (SOD1, SOD2, SOD3, CAT, GPX1, GPX2, GPX3, and GPX4) by quantitative real-time PCR. AgNP-treated cells showed a significant suppression of the expression level of SOD2 and CAT. SOD: superoxide dismutase; CAT: catalase; GPX: glutathione peroxidase. * p < 0.05; ** p < 0.01.
Figure 3. Modulation of reactive oxygen species (ROS) generation, mitochondrial depolarization, and the genes encoding the antioxidant enzymes expression in AgNP- and RA-treated SH-SY5Y cells. (A,B) ROS generation in SH-SY5Y cells pretreated with NAC (1 mM), and were then treated with 0.1 μM of AgNP or 1 μM of RA or 100 μM of Hydrogen peroxide (H2O2) was measured by fluorescence microscopy (A) and a fluorometric method (B). AgNP-exposed cells showed a significant ROS generation, in particular, after 3 h and 6 h of incubation, which is inhibited by NAC pretreatment. * p < 0.05; ** p < 0.01; *** p < 0.001. (C) SH-SY5Y cells were incubated with AgNP (0.1, 0.2, 0.3, and 0.4 μM) and the mitochondrial membrane potential (ΔΨm) was measured using JC-1 staining. The qualitative analysis fluorescence intensities of the monomer (green) and an aggregate (red) form was analyzed with the fluorescence confocal microscopy. Scale bars, 100 μm. (D) The quantitative analysis of the ratio of aggregate and the monomer was determined using dual-scanning microplate spectrofluorometer. AgNP showed a significant depolarization of the mitochondrial membrane in a dose-dependent manner in SH-SY5Y cells. * p < 0.05; ** p < 0.01; *** p < 0.001. (E) Expression of genes encoding the antioxidant enzymes (SOD1, SOD2, SOD3, CAT, GPX1, GPX2, GPX3, and GPX4) by quantitative real-time PCR. AgNP-treated cells showed a significant suppression of the expression level of SOD2 and CAT. SOD: superoxide dismutase; CAT: catalase; GPX: glutathione peroxidase. * p < 0.05; ** p < 0.01.
Ijms 19 01470 g003
Ijms 19 01470 g004a 550Ijms 19 01470 g004b 550
Figure 4. Roles of inhibitors of ROS generation and ERK/AKT signaling in the modulation of AgNP- and RA-induced neurite growth. (A) Immunocytochemistry analysis of the expression level of the neuronal differentiation marker β-tubulin III (green florescence) of SH-SY5Y cells pretreated with the antioxidant NAC (1 mM), the ERK inhibitor PD98059 (10 μM), or the AKT inhibitor LY-294002 (10 μM) for 1 h, and then exposed to 0.1 μM AgNP or 1 μM RA for five days. Scale bars, 100 μm. (B) Neurite length and the percentage of neurite-bearing cells were measured using the neurite tracing plugin NeuriteTrace in ImageJ. The pretreatment of NAC and PD98059 significantly abolished AgNP-induced neurite growth and high neurite-bearing cells percentage, but LY-294002 pretreatment markedly suppressed the RA-induced neurite growth. * p < 0.05; ** p < 0.01. (C) The expression of the neuronal differentiation-specific markers microtubule-associated protein 2 (MAP2) and β-tubulin III was measured by quantitative real-time PCR in cells that were pretreated and AgNP- or RA-exposed, as above. The expression level of the neuronal differentiation markers in AgNP- and RA-treated cells after the pretreatment of the aforementioned inhibitors confirmed the immunocytochemistry results. * p < 0.05; ** p < 0.01.
Figure 4. Roles of inhibitors of ROS generation and ERK/AKT signaling in the modulation of AgNP- and RA-induced neurite growth. (A) Immunocytochemistry analysis of the expression level of the neuronal differentiation marker β-tubulin III (green florescence) of SH-SY5Y cells pretreated with the antioxidant NAC (1 mM), the ERK inhibitor PD98059 (10 μM), or the AKT inhibitor LY-294002 (10 μM) for 1 h, and then exposed to 0.1 μM AgNP or 1 μM RA for five days. Scale bars, 100 μm. (B) Neurite length and the percentage of neurite-bearing cells were measured using the neurite tracing plugin NeuriteTrace in ImageJ. The pretreatment of NAC and PD98059 significantly abolished AgNP-induced neurite growth and high neurite-bearing cells percentage, but LY-294002 pretreatment markedly suppressed the RA-induced neurite growth. * p < 0.05; ** p < 0.01. (C) The expression of the neuronal differentiation-specific markers microtubule-associated protein 2 (MAP2) and β-tubulin III was measured by quantitative real-time PCR in cells that were pretreated and AgNP- or RA-exposed, as above. The expression level of the neuronal differentiation markers in AgNP- and RA-treated cells after the pretreatment of the aforementioned inhibitors confirmed the immunocytochemistry results. * p < 0.05; ** p < 0.01.
Ijms 19 01470 g004aIjms 19 01470 g004b
Ijms 19 01470 g005 550
Figure 5. Hypothetical model of the mechanisms of AgNP- and RA-induced neuronal differentiation of SH-SY5Y cells.
Figure 5. Hypothetical model of the mechanisms of AgNP- and RA-induced neuronal differentiation of SH-SY5Y cells.
Ijms 19 01470 g005
Table
Table 1. Primer sequences for neuronal differentiation markers, DUSPs genes, and oxidative-related genes.
Table 1. Primer sequences for neuronal differentiation markers, DUSPs genes, and oxidative-related genes.
GenesForward PrimerReverse Primer
Neuronal markersMAP2GCTCTCTGAAGAACATCCGCGGGCTTTAGCATGCTCTCTG
β-tubulin IIITCTCACAAGTACGTGCCTCGCTCCGTGTAGTGACCCTTGG
DUSPs-related genesDusp-1ACCACAAGGCAGACATCAGAAGGTAAGCAAGGCAGATGG
Dusp-2CAGCTGCTGCAGTTTGAGACAGCTGATTTCTGCCAGAGGA
Dusp-3GATCTCAACGACCTGCTCTCATGGGTGATGCCTAGTTTCTG
Dusp-4ACGGCTCTGTTGAATGTCTCCAGTCCTTCACGGCATCG
Dusp-6ACAAGCAAATCCCCATCTCGCAGCCAAGCAATGTACCAAG
Dusp-7AACCTACCCAACGCCTTCCACCAGGACACCACACTTC
Dusp-9GAGGCTTCAGCAGATTCCAGATTGAGGATGTAGCGGATGC
Oxidative-related genesSOD1GGTGGGCCAAAGGATGAAGAGCCACAAGCCAAACGACTTCC
SOD2GCTCCGGTTTTGGGGTATCTGGCGTTGATGTGAGGTTCCAG
SOD3ATGCGTGCGCTACTGTGTTCCTCCGCCGAGTCAGAGTTG
CATCTCCGCCGAGTCAGAGTTGCCTTTGCCTTGGAGTATTTGGTA
GPX1CAGTCGGTGTATGCCTTCTCGGAGGGACGCCACATTCTCG
GPX2GGTAGATTTCAATACGTTCCGGGTGACAGTTCTCCTGATGTCCAAA
GPX3AGAGCCGGGGACAAGAGAAATTTGCCAGCATACTGCTTGA
GPX4GAGGCAAGACCGAAGTAAACTACCCGAACTGGTTACACGGGAA
Housekeeping geneGAPDHAATCCCATCACCATCTTCCAGAAATGAGCCCCAGCCTTC

Share and Cite

MDPI and ACS Style

Abdal Dayem, A.; Lee, S.B.; Choi, H.Y.; Cho, S.-G. Silver Nanoparticles: Two-Faced Neuronal Differentiation-Inducing Material in Neuroblastoma (SH-SY5Y) Cells. Int. J. Mol. Sci. 2018, 19, 1470. https://doi.org/10.3390/ijms19051470

AMA Style

Abdal Dayem A, Lee SB, Choi HY, Cho S-G. Silver Nanoparticles: Two-Faced Neuronal Differentiation-Inducing Material in Neuroblastoma (SH-SY5Y) Cells. International Journal of Molecular Sciences. 2018; 19(5):1470. https://doi.org/10.3390/ijms19051470

Chicago/Turabian Style

Abdal Dayem, Ahmed, Soo Bin Lee, Hye Yeon Choi, and Ssang-Goo Cho. 2018. "Silver Nanoparticles: Two-Faced Neuronal Differentiation-Inducing Material in Neuroblastoma (SH-SY5Y) Cells" International Journal of Molecular Sciences 19, no. 5: 1470. https://doi.org/10.3390/ijms19051470

APA Style

Abdal Dayem, A., Lee, S. B., Choi, H. Y., & Cho, S. -G. (2018). Silver Nanoparticles: Two-Faced Neuronal Differentiation-Inducing Material in Neuroblastoma (SH-SY5Y) Cells. International Journal of Molecular Sciences, 19(5), 1470. https://doi.org/10.3390/ijms19051470

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop